Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder

Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

(2016) Richard Weisler et al.   CNS SPECTRUMS

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram

(2013) Madhukar H. Trivedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

Contribution of Rating Scales to the Assessment of Executive Functions

(2013) Peter K. Isquith et al.   Applied Neuropsychology-Child

Computerized Neuropsychological Testing to Rapidly Evaluate Cognition in Pediatric Patients With Neurologic Disorders

(2012) Brian L. Brooks et al.   JOURNAL OF CHILD NEUROLOGY

Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review.

(2012) Hannah R. Snyder   PSYCHOLOGICAL BULLETIN

Identifying a cognitive impairment subgroup in adults with mood disorders

(2011) Grant L. Iverson et al.   JOURNAL OF AFFECTIVE DISORDERS

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

(2010) Timothy Wigal et al.   Behavioral and Brain Functions

Academic procrastination in college students: The role of self-reported executive function

(2010) Laura A. Rabin et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder

(2010) Ixchel Herrera-Guzmán et al.   PSYCHIATRY RESEARCH

Subjective rating of working memory is associated with frontal lobe volume in schizophrenia

(2010) Matthew A. Garlinghouse et al.   SCHIZOPHRENIA RESEARCH

Identifying Neurocognitive Impairment in Depression Using Computerized Testing

(2009) Grant L. Iverson et al.   APPLIED NEUROPSYCHOLOGY

Cognitive impairment in major depression

(2009) Donatella Marazziti et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Health related quality of life in recurrent depression: A comparison with a general population sample

(2009) Mascha C. ten Doesschate et al.   JOURNAL OF AFFECTIVE DISORDERS

Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis

(2009) André Russowsky Brunoni et al.   PLoS One

Cognitive deficits in the euthymic phase of unipolar depression

(2009) Marek Preiss et al.   PSYCHIATRY RESEARCH

A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

(2008) Rossella Medori et al.   BIOLOGICAL PSYCHIATRY

Sex Differences in Cognitive Estimation During Sleep Deprivation: Effects of Stimulant Countermeasures

(2008) William D. S. Killgore et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis

(2008) S. Reppermund et al.   PSYCHOLOGICAL MEDICINE

Cognitive and Behavioral Effects of Multilayer-Release Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

(2007) Russell Schachar et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY